Xiaodong Yu

572 total citations
26 papers, 449 citations indexed

About

Xiaodong Yu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaodong Yu has authored 26 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaodong Yu's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). Xiaodong Yu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). Xiaodong Yu collaborates with scholars based in China, United States and Sweden. Xiaodong Yu's co-authors include Feng Ding, Tianyue Li, Dongsheng Li, Wei Wang, Min Zhang, Tao Yang, Amir A. Jazaeri, R. Stephens, Brian P. Hibler and John I. Risinger and has published in prestigious journals such as Oncogene, Scientific Reports and BioMed Research International.

In The Last Decade

Xiaodong Yu

24 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaodong Yu China 12 294 249 80 69 55 26 449
Dan‐Ming Wei China 11 271 0.9× 182 0.7× 59 0.7× 74 1.1× 36 0.7× 26 422
Jinsei Miyoshi Japan 8 312 1.1× 196 0.8× 76 0.9× 46 0.7× 35 0.6× 17 434
Ankui Yang China 15 253 0.9× 167 0.7× 147 1.8× 72 1.0× 29 0.5× 25 442
Jin-ping Ma China 13 323 1.1× 164 0.7× 125 1.6× 98 1.4× 68 1.2× 41 514
Shengli Yang China 10 247 0.8× 143 0.6× 73 0.9× 51 0.7× 38 0.7× 24 361
Longci Sun China 9 197 0.7× 127 0.5× 53 0.7× 71 1.0× 32 0.6× 17 327
Yuki Oda Japan 11 218 0.7× 163 0.7× 67 0.8× 41 0.6× 29 0.5× 31 380
Jun Meng China 11 184 0.6× 136 0.5× 115 1.4× 75 1.1× 42 0.8× 23 392
Shuoer Wang China 10 159 0.5× 129 0.5× 124 1.6× 55 0.8× 29 0.5× 16 323

Countries citing papers authored by Xiaodong Yu

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Yu more than expected).

Fields of papers citing papers by Xiaodong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Yu. The network helps show where Xiaodong Yu may publish in the future.

Co-authorship network of co-authors of Xiaodong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Yu. A scholar is included among the top collaborators of Xiaodong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Yu. Xiaodong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Xia, Long, et al.. (2024). A Mendelian randomization study between metabolic syndrome and its components with prostate cancer. Scientific Reports. 14(1). 14338–14338. 3 indexed citations
4.
Yu, Xiaodong, et al.. (2024). Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer. Pharmacological Reports. 76(2). 273–286. 4 indexed citations
5.
Yu, Xiaodong, et al.. (2024). Quercetin conjugated PSC-derived exosomes to inhibit intimal hyperplasia via modulating the ERK, Akt, and NF-κB signaling pathways in the rat carotid artery post balloon injury. Nanomedicine Nanotechnology Biology and Medicine. 61. 102763–102763. 2 indexed citations
6.
7.
Li, Junyang, et al.. (2023). Perioperative results of single-port vs multi-port robotic-assisted radical prostatectomy via peritoneal approach: a meta-analysis. Journal of Robotic Surgery. 17(4). 1309–1318. 3 indexed citations
8.
9.
Yu, Xiaodong, et al.. (2023). METTL3 regulates FAM83D m6A modification to accelerate tumorigenesis of triple-negative breast cancer via the Wnt/β-catenin pathway. Toxicology in Vitro. 95. 105746–105746. 6 indexed citations
10.
11.
Tian, Jing, et al.. (2023). Methionine enkephalin(MENK) upregulated memory T cells in anti-influenza response. BMC Immunology. 24(1). 38–38. 1 indexed citations
12.
Li, Kunpeng, Xiaodong Yu, Xuesong Yang, et al.. (2021). Perioperative and Oncologic Outcomes of Single-Port vs Multiport Robot-Assisted Radical Prostatectomy: A Meta-Analysis. Journal of Endourology. 36(1). 83–98. 23 indexed citations
13.
Du, Zhongbo, Li Luo, Wei Sun, et al.. (2021). Systematic Evaluation for the Influences of the SOX17/Notch Receptor Family Members on Reversing Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells. Frontiers in Oncology. 11. 607291–607291. 12 indexed citations
14.
Yu, Xiaodong, Chunsheng Wang, Meng Li, et al.. (2021). Construction of ceRNA regulatory network in mice with Echinococcosis-induced allergic reactions. Acta Tropica. 224. 106120–106120. 2 indexed citations
15.
Zhang, Qiang, Xiaoyan Jin, Xin Chen, et al.. (2020). A long non-coding RNA LINC00461-dependent mechanism underlying breast cancer invasion and migration via the miR-144-3p/KPNA2 axis. Cancer Cell International. 20(1). 137–137. 15 indexed citations
16.
Li, Hao, et al.. (2020). LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells. Molecular and Cellular Probes. 54. 101667–101667. 15 indexed citations
17.
Yu, Xiaodong, et al.. (2016). Truncation, modification, and optimization of MIG6segment 2 peptide to target lung cancer-related EGFR. Computational Biology and Chemistry. 61. 251–257. 12 indexed citations
18.
Zhang, Min, Wei Wang, Tianyue Li, et al.. (2016). Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis. Biomedicine & Pharmacotherapy. 80. 73–79. 135 indexed citations
19.
Aprelikova, Olga, Brian P. Hibler, Xiaodong Yu, et al.. (2012). Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility. Oncogene. 32(27). 3246–3253. 107 indexed citations
20.
Yu, Xiaodong. (1998). The role of B7-CD28 co-stimulation in tumor rejection. International Immunology. 10(6). 791–797. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dan‐Ming Wei Breakdown of academic impact, for papers by Jinsei Miyoshi Breakdown of academic impact, for papers by Ankui Yang Breakdown of academic impact, for papers by Jin-ping Ma Breakdown of academic impact, for papers by Shengli Yang Breakdown of academic impact, for papers by Longci Sun Breakdown of academic impact, for papers by Yuki Oda Breakdown of academic impact, for papers by Jun Meng Breakdown of academic impact, for papers by Shuoer Wang
Rankless by CCL
2026